US Broker Ratings

Yalla Group Limited (YALA) Stock Analysis: Exploring a 13.76% Potential Upside in MENA’s Social Networking Market

Yalla Group Limited (NASDAQ: YALA), a prominent player in the technology sector, has been gaining attention with its unique position in the Middle East and North Africa (MENA) region’s social..

Terns Pharmaceuticals, Inc. (TERN) Stock Analysis: A 445% Upside Potential with Strong Buy Ratings

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) is capturing the attention of investors in the biotechnology sector with its promising pipeline of small-molecule therapies targeting oncology and obesity. Headquartered in Foster City,..

Canopy Growth Corporation (CGC) Stock Analysis: Navigating Potential Upside Amid Industry Challenges

Canopy Growth Corporation (CGC) stands as a prominent player in the cannabis sector, a market that’s both promising and fraught with challenges. Listed under the healthcare sector and operating within..

Rigel Pharmaceuticals (RIGL) Stock Analysis: Exploring a 64% Potential Upside in the Biotech Sector

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a dynamic player in the biotechnology industry, offers intriguing prospects for investors seeking opportunities in the healthcare sector. With its focus on developing innovative therapies..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: A 123% Potential Upside in the Healthcare Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing investor attention with its promising prospects in the dynamic healthcare sector. Specializing in medical devices, the company is pioneering advancements in minimally invasive..

National Research Corporation (NRC): Investor Outlook on a High ROE Healthcare Analytics Company

National Research Corporation (NRC), a prominent player in the healthcare sector, is a company that delivers crucial insights and analytics to enhance patient and employee experiences. With a market capitalization..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring a 25% Upside Potential

Fair Isaac Corporation (FICO), a pivotal player in the technology sector, specializes in software applications that empower businesses to automate and enhance decision-making processes. With a robust market capitalization of..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a Potential 100% Upside

Investors looking for opportunities in the healthcare sector may find Varex Imaging Corporation (NASDAQ: VREX) an intriguing prospect. Despite challenges reflected in its recent financial performance, the company’s stock currently..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Unpacking a Potential 279% Upside

Investors seeking high-growth opportunities in the biotechnology sector may find Cartesian Therapeutics, Inc. (RNAC) worth a closer look. Positioned in the healthcare sector, this clinical-stage biotechnology company is pioneering mRNA..

XOMA Royalty Corporation (XOMA) Stock Analysis: A Biotechnology Play with a 158.67% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA) stands out in the biotechnology sector with a business model that capitalizes on royalty revenues and milestone payments from a diverse portfolio of therapeutic candidates...

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a 444% Potential Upside with Strong Buy Ratings

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) presents a compelling opportunity for investors keen on the biotechnology sector, with a remarkable potential upside of 444.87% as indicated by its current analyst..

Benitec Biopharma Inc. (BNTC) Stock Report: A 66% Potential Upside Beckons Investors in the Biotech Sector

Benitec Biopharma Inc. (NASDAQ: BNTC), headquartered in Hayward, California, is a captivating player within the biotechnology sector. Specializing in DNA-directed RNA interference-based therapeutics, the company is at the forefront of..

Aurora Cannabis Inc. (ACB) Stock Analysis: Revenue Growth Shines Amidst Valuation Challenges

Aurora Cannabis Inc. (NYSE: ACB), a prominent player in the healthcare sector specializing in the production and distribution of cannabis products, has been making waves with its impressive revenue growth...

TruBridge, Inc. (TBRG): Uncovering a 24% Potential Upside in Healthcare Information Services

TruBridge, Inc. (NASDAQ: TBRG) is carving a niche in the healthcare sector with its focus on providing innovative solutions to community hospitals, clinics, and healthcare systems both in the United..

UroGen Pharma Ltd. (URGN) Stock Analysis: A Biotech Play with Over 300% Potential Upside

UroGen Pharma Ltd. (NASDAQ: URGN) is capturing the attention of investors with its impressive potential upside of over 300%, according to analyst ratings. Specializing in innovative treatments for urothelial and..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 209% Potential Upside in the Biotech Sector

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is catching the attention of investors with its promising pipeline in gene and cell therapies targeted at life-threatening diseases. With a..

Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Evaluating Its 4.46% Potential Upside

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), a key player in the biotechnology sector, is making headlines with its strategic focus on immunotherapy and targeted oncology treatments. Based in Waltham, Massachusetts, the..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating the Healthcare Sector with a 52-Week High of $14.15

Zhengye Biotechnology Holding L (ZYBT), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is making waves with its focus on veterinary vaccines...

Establishment Labs Holdings Inc (ESTA): Investor Outlook Reveals 56% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents a compelling case with its significant market presence and robust growth prospects. Headquartered in Alajuela,..

Mineralys Therapeutics, Inc. (MLYS) Investor Outlook: Analyzing a Potential 150% Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has captured the attention of investors with a potential upside of 150.23%, making this biotech firm a company to watch closely. Specializing in biopharmaceutical solutions,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds